Nasara, Aiza .

HRN: 15-11-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
METRONIDAZOLE 500MG (TAB)
11/23/2025
11/30/2025
ORAL
500mg
TID
Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines